Clinical trial
Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and…
NCT00002427 · Research Institute for Genetic and Human Therapy, Other · Completed
Key facts
| NCT number | NCT00002427 |
|---|---|
| Title | Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults |
| Official title | A Phase I/II Study of the Safety and Antiretroviral Activity of Nine Hydroxyurea Regimens in Combination With ddI and d4T in Subjects With HIV Infection |
| Lead sponsor | Research Institute for Genetic and Human Therapy, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Hydroxyurea, Stavudine, Didanosine |
| Enrollment | 225 |
| Start date | May 1, 1999 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: